188 related articles for article (PubMed ID: 29313486)
1. Phase III Clinical Trial to Evaluate Ivermectin in the Reduction of
de Almeida Basano S; de Souza Almeida Aranha Camargo J; Fontes G; Pereira AR; Medeiros JF; de Oliveira Laudisse MC; de Godoi Mattos Ferreira R; Camargo LMA
Am J Trop Med Hyg; 2018 Mar; 98(3):786-790. PubMed ID: 29313486
[TBL] [Abstract][Full Text] [Related]
2. Sustained clearance of Mansonella ozzardi infection after treatment with ivermectin in the Brazilian Amazon.
Basano Sde A; Fontes G; Medeiros JF; Aranha Camargo JS; Souza Vera LJ; Parente Araújo MP; Pires Parente MS; Mattos Ferreira Rde G; Barreto Crispim Pd; Aranha Camargo LM
Am J Trop Med Hyg; 2014 Jun; 90(6):1170-5. PubMed ID: 24710613
[TBL] [Abstract][Full Text] [Related]
3. Ivermectin in the successful treatment of a patient with Mansonella ozzardi infection.
Nutman TB; Nash TE; Ottesen EA
J Infect Dis; 1987 Oct; 156(4):662-5. PubMed ID: 3305722
[No Abstract] [Full Text] [Related]
4. Ivermectin-related adverse clinical events in patients treated for Mansonella ozzardi infections.
Krolewiecki AJ; Cajal SP; Villalpando C; Gil JF
Rev Argent Microbiol; 2011; 43(1):48-50. PubMed ID: 21491068
[TBL] [Abstract][Full Text] [Related]
5. Ivermectin treatment of mansonellosis in Trinidad.
Gonzalez AA; Chadee DD; Rawlins SC
West Indian Med J; 1999 Dec; 48(4):231-4. PubMed ID: 10639847
[TBL] [Abstract][Full Text] [Related]
6. Current profile of Mansonella ozzardi (Nematoda: Onchocercidae) in communities along the Ituxi river, Lábrea municipality, Amazonas, Brazil.
Medeiros JF; Py-Daniel V; Barbosa UC; Ogawa GM
Mem Inst Oswaldo Cruz; 2008 Jun; 103(4):409-11. PubMed ID: 18660999
[TBL] [Abstract][Full Text] [Related]
7. Occurrence of Mansonella ozzardi diagnosed using a polycarbonate membrane in a riverside population of Lábrea in the Western Brazilian Amazon.
Basano Sde A; Medeiros JF; Fontes G; Vieira Gde D; Camargo JS; Vera LJ; Ferreira Rde G; Camargo LM
Rev Soc Bras Med Trop; 2016 Feb; 49(1):115-8. PubMed ID: 27163575
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of ivermectin in the treatment of concomitant Mansonella perstans infections in onchocerciasis patients.
Schulz-Key H; Albrecht W; Heuschkel C; Soboslay PT; Banla M; Görgen H
Trans R Soc Trop Med Hyg; 1993; 87(2):227-9. PubMed ID: 8337736
[TBL] [Abstract][Full Text] [Related]
9. Simuliid blackflies (Diptera: Simuliidae) and ceratopogonid midges (Diptera: Ceratopogonidae) as vectors of Mansonella ozzardi (Nematoda: Onchocercidae) in northern Argentina.
Shelley AJ; Coscarón S
Mem Inst Oswaldo Cruz; 2001 May; 96(4):451-8. PubMed ID: 11391415
[TBL] [Abstract][Full Text] [Related]
10. Mansonella ozzardi: a neglected New World filarial nematode.
Lima NF; Veggiani Aybar CA; Dantur Juri MJ; Ferreira MU
Pathog Glob Health; 2016 May; 110(3):97-107. PubMed ID: 27376501
[TBL] [Abstract][Full Text] [Related]
11. Treatment of human Mansonella streptocerca infection with ivermectin.
Fischer P; Bamuhiiga J; Büttner DW
Trop Med Int Health; 1997 Feb; 2(2):191-9. PubMed ID: 9472305
[TBL] [Abstract][Full Text] [Related]
12. Update on the distribution of Mansonella perstans in the southern part of Cameroon: influence of ecological factors and mass drug administration with ivermectin.
Wanji S; Tayong DB; Layland LE; Datchoua Poutcheu FR; Ndongmo WP; Kengne-Ouafo JA; Ritter M; Amvongo-Adjia N; Fombad FF; Njeshi CN; Nkwescheu AS; Enyong PA; Hoerauf A
Parasit Vectors; 2016 May; 9(1):311. PubMed ID: 27245442
[TBL] [Abstract][Full Text] [Related]
13. Detection of Mansonella ozzardi among blood donors from highly endemic interior cities of Amazonas state, northern Brazil.
Abrahim CMM; Py-Daniel V; Luz SLB; Fraiji NA; Stefani MMA
Transfusion; 2019 Mar; 59(3):1044-1051. PubMed ID: 30566229
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of diagnostic methods for Mansonella ozzardi microfilariae detection in the Brazilian Amazon Region.
Medeiros JF; Fontes G; Nascimento VLD; Rodrigues M; Cohen J; Andrade EV; Pessoa FAC; Martins M
Mem Inst Oswaldo Cruz; 2018 Mar; 113(3):173-177. PubMed ID: 29412356
[TBL] [Abstract][Full Text] [Related]
15. Ivermectin in loiasis and concomitant O. volvulus and M. perstans infections.
Richard-Lenoble D; Kombila M; Rupp EA; Pappayliou ES; Gaxotte P; Nguiri C; Aziz MA
Am J Trop Med Hyg; 1988 Nov; 39(5):480-3. PubMed ID: 3195695
[TBL] [Abstract][Full Text] [Related]
16. The search for better treatment strategies for mansonellosis: an expert perspective.
Ferreira MU; Crainey JL; Gobbi FG
Expert Opin Pharmacother; 2023; 24(15):1685-1692. PubMed ID: 37477269
[TBL] [Abstract][Full Text] [Related]
17. Treatment failure of a single high dose of ivermectin for Mansonella perstans filariasis.
Van den Enden E; Van Gompel A; Van der Stuyft P; Vervoort T; Van den Ende J
Trans R Soc Trop Med Hyg; 1993; 87(1):90. PubMed ID: 8465410
[TBL] [Abstract][Full Text] [Related]
18. Atypical Mansonella ozzardi Microfilariae from an Endemic Area of Brazilian Amazonia.
Ta-Tang TH; Luz SL; Merino FJ; de Fuentes I; López-Vélez R; Almeida TA; Lanza M; Abrahim CM; Rubio JM
Am J Trop Med Hyg; 2016 Sep; 95(3):629-32. PubMed ID: 27402517
[TBL] [Abstract][Full Text] [Related]
19. Long-term suppression of Mansonella streptocerca microfilariae after treatment with ivermectin.
Fischer P; Tukesiga E; Büttner DW
J Infect Dis; 1999 Oct; 180(4):1403-5. PubMed ID: 10479183
[TBL] [Abstract][Full Text] [Related]
20. Immune response in Mansonella ozzardi infection modulated by IL-6/IL-10 axis in Amazon region of Brazil.
Costa AG; Sadahiro A; Monteiro Tarragô A; Pessoa FAC; Pires Loiola B; Malheiro A; Medeiros JF
Cytokine; 2018 Apr; 104():98-103. PubMed ID: 29032984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
